Soleno Therapeutics (SLNO) EBT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67% |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 83.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.49% |
| Dec 31, 2025 | 113.48% |
| Sep 30, 2025 | 83.43% |
| Jun 30, 2025 | 11.44% |
| Mar 31, 2025 | -96.46% |
| Dec 31, 2024 | -164.85% |
| Sep 30, 2024 | -109.89% |
| Jun 30, 2024 | -25.39% |
| Mar 31, 2024 | -32.71% |
| Dec 31, 2023 | -13.93% |
| Sep 30, 2023 | -9.12% |
| Jun 30, 2023 | 8.85% |
| Mar 31, 2023 | 3.44% |
| Dec 31, 2022 | 5.99% |
| Sep 30, 2022 | -0.55% |
| Jun 30, 2022 | -6.43% |
| Mar 31, 2022 | -5.06% |
| Dec 31, 2021 | 5.31% |
| Sep 30, 2021 | -28.80% |
| Jun 30, 2021 | -48.09% |
| Mar 31, 2021 | -38.12% |
| Dec 31, 2020 | -15.24% |
| Sep 30, 2020 | -44.08% |
| Jun 30, 2020 | -55.71% |
| Mar 31, 2020 | -89.13% |
| Dec 31, 2019 | -54.44% |
| Sep 30, 2019 | -46.07% |
| Jun 30, 2019 | -34.81% |
| Mar 31, 2019 | -5.30% |
| Dec 31, 2018 | -0.28% |
| Sep 30, 2018 | -6.80% |
| Jun 30, 2018 | -3.89% |
| Mar 31, 2018 | -12.71% |
| Dec 31, 2017 | -7.66% |
| Sep 30, 2017 | -8.18% |
| Jun 30, 2017 | -14.46% |
| Mar 31, 2017 | -8.57% |
| Dec 31, 2016 | -28.24% |
| Sep 30, 2016 | -7.96% |